Musclepharm Corp Stock Shares Outstanding
| MSLPDelisted Stock | USD 0 0.0002 15.38% |
Musclepharm Corp fundamentals help investors to digest information that contributes to Musclepharm Corp's financial success or failures. It also enables traders to predict the movement of Musclepharm Pink Sheet. The fundamental analysis module provides a way to measure Musclepharm Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Musclepharm Corp pink sheet.
Musclepharm |
Musclepharm Corp Company Shares Outstanding Analysis
Musclepharm Corp's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Musclepharm Corp Shares Outstanding | 34.35 M |
Most of Musclepharm Corp's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Musclepharm Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Musclepharm Corp has 34.35 M of shares currently outstending. This is 91.75% lower than that of the Personal Products sector and 86.75% lower than that of the Consumer Staples industry. The shares outstanding for all United States stocks is 93.99% higher than that of the company.
Musclepharm Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Musclepharm Corp's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Musclepharm Corp could also be used in its relative valuation, which is a method of valuing Musclepharm Corp by comparing valuation metrics of similar companies.Musclepharm Corp is currently under evaluation in shares outstanding category among related companies.
Musclepharm Fundamentals
| Return On Asset | -0.66 | |||
| Profit Margin | (0.39) % | |||
| Operating Margin | (0.23) % | |||
| Current Valuation | 22.12 M | |||
| Shares Outstanding | 34.35 M | |||
| Shares Owned By Insiders | 53.50 % | |||
| Shares Owned By Institutions | 15.05 % | |||
| Price To Sales | 0 X | |||
| Revenue | 50.04 M | |||
| Gross Profit | 5.37 M | |||
| EBITDA | (7.07 M) | |||
| Net Income | (12.87 M) | |||
| Cash And Equivalents | 534 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 22.64 M | |||
| Debt To Equity | 0.56 % | |||
| Current Ratio | 0.25 X | |||
| Book Value Per Share | (1.14) X | |||
| Cash Flow From Operations | (8.04 M) | |||
| Earnings Per Share | (0.58) X | |||
| Price To Earnings To Growth | (0.10) X | |||
| Target Price | 1.65 | |||
| Number Of Employees | 21 | |||
| Beta | -0.0524 | |||
| Market Capitalization | 6.87 K | |||
| Total Asset | 11.21 M | |||
| Retained Earnings | (159.76 M) | |||
| Working Capital | (20.99 M) | |||
| Current Asset | 32.9 M | |||
| Current Liabilities | 53.88 M | |||
| Z Score | -16.8 | |||
| Net Asset | 11.21 M |
About Musclepharm Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Musclepharm Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Musclepharm Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Musclepharm Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Musclepharm Pink Sheet
If you are still planning to invest in Musclepharm Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Musclepharm Corp's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |